Daxor Corp. founder and Chief Medical Officer Joseph Feldschuh died Jan. 31.
Feldschuh, who was working on a part-time basis, was the first president and CEO of the company. He was undergoing treatment for pancreatic cancer and unexpectedly developed sepsis during the last two days.
Michael Feldschuh will continue in the president and CEO role.
The transition process for the chief medical officer role was ongoing at the time of Joseph Feldschuh's death, but the company does not expect significant functional difficulties arising from the transition process and is confident in the necessary expertise and resources to meet all foreseeable future needs.